Annual report [Section 13 and 15(d), not S-K Item 405]

Consolidated Statements of Operations

v3.25.3
Consolidated Statements of Operations - USD ($)
12 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Research and development $ 15,588,185 $ 12,782,167
General and administrative 19,942,747 24,609,801
Total operating expenses 35,530,932 37,391,968
Gain on sale of ENTADFI® assets 10,780,290 1,222,908
Operating loss (24,750,642) (36,169,060)
Non-operating income (expenses):    
Gain on extinguishment of debt 8,624,778 0
Change in fair value of equity securities (323,773) (176,077)
Other income, net 768,380 1,085,199
Total non-operating income 9,069,385 909,122
Net loss from continuing operations (15,681,257) (35,259,938)
Net loss from discontinued operations, net of taxes (7,045,022) (2,541,488)
Net loss $ (22,726,279) $ (37,801,426)
Net loss from continuing operations per basic and diluted common shares outstanding (in dollars per share) $ (1.07) $ (2.61)
Net loss from discontinued operations per basic and diluted common shares outstanding (in dollars per share) (0.48) (0.19)
Net loss per basic and diluted common shares outstanding (in dollars per share) $ (1.55) $ (2.8)
Basic and diluted weighted average common shares outstanding (in shares) 14,646,294 13,487,502